Global Sterile Injectables Cdmo Market Size & Outlook
Global sterile injectables cdmo market, 2021-2033 (US$M)
Related Markets
Global sterile injectables cdmo market highlights
- The global sterile injectables cdmo market generated a revenue of USD 37,820.5 million in 2025 and is expected to reach USD 87,342.3 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 11.2% by 2033.
- In terms of segment, large molecule accounted for a revenue of USD 25,644.8 million in 2025.
- Large Molecule is the most lucrative molecule type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Global data book summary
| Market revenue in 2025 | USD 37,820.5 million |
| Market revenue in 2033 | USD 87,342.3 million |
| Growth rate | 11.2% (CAGR from 2026 to 2033) |
| Largest segment | Large molecule |
| Fastest growing segment | Large Molecule |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Small Molecule, Large Molecule |
Other key industry trends
- In terms of revenue, the North America accounted for 33.8% of the global sterile injectables cdmo market in 2025.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2033.
- By country, UK is the fastest growing regional market and is projected to reach USD 2,545.1 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Sterile Injectables CDMO Market Scope
Sterile Injectables CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Torbay Council | View profile | 1001-5000 | Torquay, Torbay, United Kingdom, Europe | https://www.torbay.gov.uk/ |
| Famar | View profile | 1001-5000 | Athens, Attiki, Greece, Europe | https://www.famar-group.com |
| Aenova Group | View profile | 5001-10000 | Greensboro, North Carolina, United States, North America | http://www.aenova-group.com |
| Fareva | View profile | 5001-10000 | Tournon-sur-rhône, Rhone-Alpes, France, Europe | http://www.fareva.com/ |
| Pfizer CentreOne | View profile | - | New York, New York, United States, North America | https://www.pfizercentreone.com |
| IDT Biologika | View profile | 1001-5000 | Dessau, Sachsen-Anhalt, Germany, Europe | https://idt-biologika.de/ |
| Ajinomoto | View profile | 10001+ | Tokyo, Tokyo, Japan, Asia | http://www.ajinomoto.com |
| Fresenius Kabi | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://www.fresenius-kabi-oncology.com/ |
| Unither Pharmaceuticals | View profile | 1001-5000 | Paris, Ile-de-France, France, Europe | https://www.unither-pharma.com/ |
| PCI Pharma Services | View profile | 1001-5000 | Philadelphia, Pennsylvania, United States, North America | http://www.pciservices.com |
| Alcami | View profile | 501-1000 | Wilmington, North Carolina, United States, North America | http://www.alcaminow.com |
| Vetter Pharma-Fertigung | View profile | 5001-10000 | Ravensburg, Baden-Wurttemberg, Germany, Europe | https://www.vetter-pharma.com/en |
| Recipharm | View profile | 1001-5000 | Jordbro, Stockholms Lan, Sweden, Europe | http://www.recipharm.com |
| Siegfried Holding AG | View profile | 4180 | Untere Bruehlstrasse 4, Zofingen, Switzerland, CH-4800 | https://www.siegfried.ch |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Eurofins Scientific SE | View profile | 61798 | 23 Val Fleuri, Luxembourg, Luxembourg, L-1526 | https://www.eurofins.com |
| Baxter International Inc | View profile | 60000 | One Baxter Parkway, Deerfield, IL, United States, 60015 | https://www.baxter.com |
Global sterile injectables cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to sterile injectables cdmo market will help companies and investors design strategic landscapes.
Large molecule was the largest segment with a revenue share of 67.81% in 2025. Horizon Databook has segmented the Global sterile injectables cdmo market based on small molecule, large molecule covering the revenue growth of each sub-segment from 2021 to 2033.
- Global Sterile Injectables CDMO Molecule Type Outlook (Revenue, USD Million, 2021-2033)
- Large Molecule
- Small Molecule
- Global Sterile Injectables CDMO Product Outlook (Revenue, USD Million, 2021-2033)
- API
- Finished Drug Product
- Pre-filled Syringes
- Vials and Ampoules
- Specialty Injectables
- Others Finished Drug Product
- Global Sterile Injectables CDMO Service Outlook (Revenue, USD Million, 2021-2033)
- Analytical and Testing Services
- Stability Testing
- Drug Substance
- Accelerated Stability Testing
- Photostability Testing
- Other Stability Testing Methods
- Stability Indicating Method Validation
- Method Development and Validation
- Others Analytical and Testing Services
- Extractable & Leachable Testing
- Stability Testing
- Formulation Development
- Storage
- Non-cold
- Cold
- Manufacturing
- Commercial Manufacturing
- Clinical Trial Manufacturing
- Aseptic Fill-Finish Services
- Others Service
- Packaging
- Analytical and Testing Services
- Global Sterile Injectables CDMO Therapeutic Area Outlook (Revenue, USD Million, 2021-2033)
- Cardiovascular Diseases
- Musculoskeletal Diseases
- Infectious Disorders
- Oncology
- Central Nervous System Diseases
- Hormonal Diseases
- Others Therapeutic Area
- Global Sterile Injectables CDMO Route of Administration Outlook (Revenue, USD Million, 2021-2033)
- Subcutaneous (SC)
- Intramuscular (IM)
- Others Route of Administration
- Intravenous (IV)
- Global Sterile Injectables CDMO End Use Outlook (Revenue, USD Million, 2021-2033)
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others End Use
Reasons to subscribe to Global sterile injectables cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global sterile injectables cdmo market databook
-
Our clientele includes a mix of sterile injectables cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global sterile injectables cdmo market , including forecasts for subscribers. This global databook contains high-level insights into Global sterile injectables cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Global sterile injectables cdmo market size, by regions, 2021-2033 (US$M)
Top 10 countries: Sterile injectables cdmo market size, 2025 (US$M)
Global sterile injectables cdmo market share, by service, 2025 & 2033 (%, US$M)
Sterile injectables cdmo market: Opportunity assessment by country
Global sterile injectables cdmo market, by region, 2025 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
